Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed CFO
Quarterly results
Director departure
Appointed director
Notes underwriting agrmnt
Acq. announced
CC transcript

INTERLEUKIN GENETICS INC (ILIU) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
08/04/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/04/2017 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/04/2017 25 Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities:
07/24/2017 8-K Quarterly results
07/03/2017 8-K Form 8-K - Current report
05/11/2017 10-Q Quarterly Report for the period ended March 31, 2017
05/01/2017 10-K/A Annual Report for the period ended December 31, 2016 [amend]
04/18/2017 10-K/A Annual Report for the period ended December 31, 2016 [amend]
04/17/2017 10-K Annual Report for the period ended December 31, 2016
04/03/2017 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
04/03/2017 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
04/03/2017 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
04/03/2017 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
03/31/2017 8-K Form 8-K - Current report
01/05/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
12/27/2016 CT ORDER Form CT ORDER - Confidential treatment order
12/23/2016 8-K Form 8-K - Current report
11/15/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/15/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/15/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/14/2016 10-Q Quarterly Report for the period ended September 30, 2016
10/24/2016 8-K Submission of Matters to a Vote of Security Holders
10/11/2016 SC 13D/A Delta Dental Plan of Michigan, Inc. reports a 4.8% stake in Interleukin Genetics, Inc.
09/30/2016 RW Form RW - Registration Withdrawal Request
09/30/2016 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Third Amendment to Commercial Lease, by and between the Company and Clematis, LLC"
09/28/2016 EFFECT Form EFFECT - Notice of Effectiveness
09/12/2016 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
09/09/2016 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/07/2016 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
08/30/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
08/30/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
08/26/2016 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Lender Warrant",
"First Amendment of Venture Loan and Security Agreement, by and among Interleukin Genetics, Inc. and Horizon Credit II LLC, as assignee of Horizon Technology Finance Corporation"
08/25/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy